Startup profile · funding coverage
Healthleap funding, valuation and investors
Clinical AI platform that screens inpatient records for conditions hospitals may miss.
Keep track of Healthleap
Save this profile to your VCT watchlist for a quick return.
Funding, valuation & investors
Answer-first snapshotLatest funding
Seed and Series A (aggregate)
$38 million · October 7, 2026
Latest known valuation
Not publicly disclosed
Total disclosed equity funding
$38M
Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.
Current status
private
series a · San Francisco, California
Investors in latest funding
Other: Sequoia Capital , First Round Capital , Hummingbird Ventures
Overview
San Francisco clinical AI company whose software continuously analyzes inpatient records to flag patients at risk of undiagnosed conditions, beginning with malnutrition.
Why Healthleap is interesting
Healthleap links AI screening to both patient outcomes and hospital reimbursement, creating measurable ROI but raising high clinical-validation and workflow-integration requirements.
Product & use cases
EHR-integrated screening software that reviews notes, labs, vitals, orders and problem lists to prioritize patients for clinician attention.
Key facts
- Screens adult inpatients daily at more than 20 hospitals, according to the company.
- Named customers include Penn Medicine, Houston Methodist, Cedars-Sinai and Emory Healthcare.
Funding history (newest first)
Seed and Series A (aggregate)
2026-10-07 $38 millionSource: https://healthleap.ai/series-a
Investors in our directory
Funds linked from Healthleap's profile — open a fund page for stage focus and related deal articles.
Competitive landscape
Edge: The product is deployed across more than 20 hospitals and targets conditions that are frequently missed by manual screening.
Competes with clinical decision-support vendors, EHR-native tools and specialist diagnostic-AI companies. Adoption depends on validation, alert precision, workflow fit and reimbursement durability.
-
Epic Systems incumbent
Incumbent EHR provider with native decision-support capabilities.
-
Abridge adjacent
Healthcare AI platform focused on clinical documentation rather than inpatient risk screening.
Industries
Market / IPO context
Editorial / static context — not a live quote.
Related funding articles
Venture Capital Tracker pieces that cover Healthleap's financing or category context.
Last updated:
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.